Together Pharma Ltd (TGTR.TA)
ILA 421.9
(-1.29%)
ILA 421.9
(-1.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.52 Million ILS | -6.65% |
| 2022 | 13.42 Million ILS | 48.63% |
| 2021 | 9.02 Million ILS | -19.07% |
| 2020 | 11.15 Million ILS | -22.96% |
| 2019 | 14.48 Million ILS | -90.07% |
| 2018 | 145.78 Million ILS | 285749.02% |
| 2017 | 51 Thousand ILS | -97.45% |
| 2016 | 1.99 Million ILS | -40.33% |
| 2015 | 3.35 Million ILS | -61.05% |
| 2014 | 8.6 Million ILS | 76.33% |
| 2013 | 4.87 Million ILS | -62.61% |
| 2012 | 13.04 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.37 Million ILS | 7.82% |
| 2024 Q2 | 3.37 Million ILS | 0.0% |
| 2023 Q2 | 3.23 Million ILS | 0.0% |
| 2023 Q3 | 3.91 Million ILA | 21.15% |
| 2023 Q4 | 3.12 Million ILS | -20.18% |
| 2023 FY | 14.3 Million ILS | 6.57% |
| 2023 Q1 | 3.23 Million ILS | -0.95% |
| 2022 FY | 13.42 Million ILS | 48.63% |
| 2022 Q1 | 3.44 Million ILS | 176.97% |
| 2022 Q2 | 3.44 Million ILS | 0.0% |
| 2022 Q3 | 3.26 Million ILS | -5.25% |
| 2022 Q4 | 3.26 Million ILS | 0.0% |
| 2021 FY | 9.02 Million ILS | -19.07% |
| 2021 Q4 | 1.24 Million ILS | -52.48% |
| 2021 Q3 | 2.61 Million ILS | 5.52% |
| 2021 Q2 | 2.48 Million ILS | 10.71% |
| 2021 Q1 | 2.24 Million ILS | -8.0% |
| 2020 Q3 | 2.75 Million ILS | 2.11% |
| 2020 Q2 | 2.7 Million ILS | -14.66% |
| 2020 FY | 11.15 Million ILS | -22.96% |
| 2020 Q1 | 3.16 Million ILS | -5.55% |
| 2020 Q4 | 2.43 Million ILS | -11.71% |
| 2019 Q1 | 3.88 Million ILS | 88.99% |
| 2019 Q4 | 3.35 Million ILS | 0.0% |
| 2019 FY | 14.48 Million ILS | -90.07% |
| 2019 Q2 | 3.88 Million ILS | 0.0% |
| 2019 Q3 | 3.35 Million ILS | -13.8% |
| 2018 Q4 | 2.05 Million ILS | 0.0% |
| 2018 Q1 | 74.94 Million ILS | 499560.0% |
| 2018 Q2 | 74.94 Million ILS | 0.0% |
| 2018 FY | 145.78 Million ILS | 285749.02% |
| 2018 Q3 | 2.05 Million ILS | -97.25% |
| 2017 Q2 | 10.5 Thousand ILS | 0.0% |
| 2017 FY | 51 Thousand ILS | -97.45% |
| 2017 Q4 | 15 Thousand ILS | 0.0% |
| 2017 Q3 | 15 Thousand ILS | 42.86% |
| 2017 Q1 | 10.5 Thousand ILS | -99.71% |
| 2016 Q4 | 3.56 Million ILS | 667.47% |
| 2016 Q2 | 1.1 Million ILS | -23.44% |
| 2016 Q3 | 464.86 Thousand ILS | -57.87% |
| 2016 Q1 | 1.44 Million ILS | -49.47% |
| 2016 FY | 1.99 Million ILS | -40.33% |
| 2015 FY | 3.35 Million ILS | -61.05% |
| 2015 Q2 | 2.08 Million ILS | -1.94% |
| 2015 Q1 | 2.12 Million ILS | 46.56% |
| 2015 Q3 | 1.97 Million ILS | -5.13% |
| 2015 Q4 | 2.85 Million ILS | 44.33% |
| 2014 Q3 | 2.44 Million ILS | -10.5% |
| 2014 Q1 | 659.6 Thousand ILS | -64.9% |
| 2014 FY | 8.6 Million ILS | 76.33% |
| 2014 Q4 | 1.44 Million ILS | -40.83% |
| 2014 Q2 | 2.73 Million ILS | 314.9% |
| 2013 Q2 | 669.01 Thousand ILS | -33.28% |
| 2013 FY | 4.87 Million ILS | -62.61% |
| 2013 Q3 | 1.36 Million ILS | 103.47% |
| 2013 Q4 | 1.87 Million ILS | 38.07% |
| 2013 Q1 | 1 Million ILS | 16.77% |
| 2012 Q4 | 858.75 Thousand ILS | -91.17% |
| 2012 FY | 13.04 Million ILS | 0.0% |
| 2012 Q3 | 9.72 Million ILS | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cannabotech LTD | 15.36 Million ILA | 18.48% |